Rising Usage of Natural & Synthetic Biomaterials for Cardiac Repair to Aid Growth
Cardiovascular diseases are considered to be one of the major causes of death worldwide. Even though there are multiple pharmacological and surgical interventions that can be applied to enhance the quality of life of the patients affected by such diseases, less-invasive and cost-effective procedures are always more preferable. Both synthetic and natural biomaterials showcase high potential in cardiac regeneration and repair. Nowadays injectable biomaterials are used the most as they preserve cardiac functions, increase angiogenesis, and reduce left ventricular dilatation. However, there are numerous strict regulatory and clinical processes that the biomaterial-based devices have to go through to ensure their quality and efficacy. It may hamper the implantable biomaterials market growth.
Leading Players operating in the Biomaterials Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Invibio Ltd
- Wright Medical Technology, Inc.
- Evonik Industries AG
- Zimmer Biomet
- DePuy Synthes Companies
- DSM Biomedical, Inc.
- Corbion NV
- Other Players
Key Players Aim to Gain Competitive Edge by Acquiring Other Companies
The market houses a large number of enterprises that are presently focusing on the strategies of acquisitions and achieving fast track approvals from the regulatory bodies for new biomaterials. Below are a couple of the latest key industry developments:
- November 2019: DiFusion, a biotechnology company based in Texas, bagged the 510K clearance from the USFDA. It was meant for the company’s Xiphos-ZF spinal interbody device. The device is created from ZFUZE, a new biomaterial industry that has proven to reduce Interleukin 6 and Interleukin 1-Beta significantly. It has also exhibited M2 macrophage response.
Reasons to Purchase this Report:
- Comprehensive analysis of the biomaterials Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
